IBA Selected as Partner for Bringing Proton Therapy to Kansas

ProteusONE proton therapy machine.

July 09, 2019

Kansas City, Kan. — The University of Kansas Health System announced today it has signed an agreement with IBA for the purchase of their Proteus®ONE system for the region's first proton therapy center. The health system anticipates breaking ground in 2019.

"In signing an agreement with IBA to install their compact Proteus One treatment room system, we have reached another key milestone in our work to transform the way healthcare is delivered in our city, state and region," said Bob Page, president and chief executive officer of The University of Kansas Health System. "We are joining an elite group of health systems and hospitals offering this leading technology."

"Proton beam therapy coming to our community is exciting for patients because we will offer treatment not currently available in this region," said Tammy Peterman, president of the Kansas City division and executive vice president, chief operating officer, chief nursing officer for The University of Kansas Health System.

Proton therapy is an advanced form of targeted radiation treatment using protons – rather than x-rays – to attack cancerous tumors, minimizing radiation exposure to healthy organs and surrounding tissue. This personalized care offers opportunities to more precisely target treatment, with fewer short- and long-term side effects, depending on each patient's unique condition.

The University of Kansas Health System first announced plans to bring this innovative treatment to Kansas in February 2019.

"Today, more and more oncology patients are accessing proton therapy. IBA is pleased to partner with The University of Kansas Health System in bringing this innovative, efficient cancer treatment close to home for their patients," said Olivier Legrain, chief executive officer of IBA. "Our mission is to increase accessibility to proton therapy and we are excited to do this at one of our nation’s best health systems."

IBA's compact single-room treatment system, Proteus®ONE, will be the centerpiece of the proton therapy center at The University of Kansas Health System. This open gantry technology will allow for easy patient access, positioning and comfort as well as precise dose delivery through Pencil Beam Scanning (PBS), advanced imaging techniques and other future industry-leading capabilities such as Spot Scanning Proton ARC therapy and FLASH therapy.

"This innovative therapy minimizes radiation exposure to healthy organs and surrounding tissue," said Terance Tsue, MD, vice president and physician-in-chief of The University of Kansas Cancer Center. "Our patients will have access to precise pencil beam dosing with the most advanced imaging techniques available."

"Proton therapy is one of the most exciting new technologies to come onboard for the treatment of cancer and making sure our patients have access to this treatment option is essential," said Roy Jensen, M.D., director of The University of Kansas Cancer Center.

The University of Kansas Health System has taken another step toward bringing proton therapy to the region

Bob Page: The University of Kansas Health System has signed an agreement with IBA to install their compact Proteus One treatment room system. This announcement represents another key milestone in our work to transform the way care is delivered in our city, state and region.

Tammy Peterman: Proton beam therapy coming to our community is exciting for patients. Because we will offer treatment not currently available in this region.

Terry Tsue: IBA is simply the world's leading provider of proton therapy for the treatment of cancer with 30 years of experience and a network of the best proton therapy centers around the globe. This innovative therapy minimizes radiation exposure to healthy organs and surrounding tissue.

Roy Jensen: That's why this technology is so useful in kids. That's why it's so useful in the brain and in head and neck region, where there are vital organs that we do not want impacted by radiation in any way, but we have to pass through them to reach the tumor.

Karen Larson: Proton beam therapy was by far one of the most important treatments that he went through. He was diagnosed with stage 4 neuroblastoma of the abdomen. I mean, we were willing to go anywhere to get it. But it is so important for people who are going through his type of treatment.

Roman Volkov: Now I'm feeling fine and like I'm in good hands.

Tammy Peterman: Instead of patients like Roman leaving the area for this kind of care, they'll be able to access this state-of-the-art treatment right here in Kansas City.

Roy Jensen: Proton therapy is, frankly, one of the most exciting new technologies to come on board for the treatment of cancer and making sure that our patients have access to this is essential.

Terry Tsue: Our patients will have access to precise, powerful, pencil beam dosing with the most advanced imaging techniques available.

Tammy Peterman: It is another example of our ability to broad personalized, precision medicine. This is also exciting for our care providers, our physicians and our staff.

Bob Page: We are joining an elite group of health systems and hospitals offering this leading technology.

Tammy Peterman: This is another example of how we're raising the bar for how care is delivered in this region.

Explore more news, events and media